Standex (SXI) director sells 50 shares under pre-set Rule 10b5-1 plan

Rhea-AI Filing Summary

Standex International director Thomas E. Chorman reported a small open-market sale of 50 shares of Common Stock. The shares were sold at an average price of $355.51 per share. After this transaction, he directly holds 12,416 shares. The sale was executed under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating it was pre-arranged rather than a discretionary trade.

Insights

Equity analyst

Pre-planned, small open-market sale with substantial holdings remaining.

Director Thomas E. Chorman sold 50 shares of Standex International common stock at $355.51 per share in an open-market transaction. Following the sale, he directly holds 12,416 shares, which indicates he retains a meaningful equity position.

The filing notes the trade was made pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025. Such plans schedule trades in advance, reducing the informational value of the timing. With only one small sale and no derivative exercises or restructurings, this looks like routine portfolio management rather than a thesis-changing move.

Insider Trade Summary 10b5-1

Net Seller: 50 shares

Net Sell 1 txn

Insider CHORMAN THOMAS E

Role Director

Sold 50 shs ($18K)

Type	Security	Shares	Price	Value
Sale	Common Stock	50	$355.51	$18K

Holdings After Transaction: Common Stock — 12,416 shares (Direct)

Footnotes (1)

1. F1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Key Figures

Shares sold: 50 shares Sale price: $355.51 per share Shares held after: 12,416 shares +2 more

5 metrics

Shares sold 50 shares Open-market sale of common stock

Sale price $355.51 per share Average transaction price

Shares held after 12,416 shares Direct ownership following sale

Net buy/sell shares 50 shares net sold transactionSummary netBuySellShares

Trading plan date November 6, 2025 Rule 10b5-1 plan referenced in footnote

Key Terms

Rule 10b5-1 trading plan, open-market sale, Form 4, Common Stock

4 terms

Rule 10b5-1 trading plan regulatory

"Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What did Standex International (SXI) director Thomas E. Chorman do in this Form 4 filing?

Thomas E. Chorman reported selling 50 shares of Standex International common stock in an open-market transaction at an average price of $355.51 per share. After this sale, he directly holds 12,416 shares, indicating he maintains a sizable ongoing stake in the company.

At what price did the SXI director sell shares and how many does he now hold?

He sold 50 Standex International shares at an average price of $355.51 per share. Following the transaction, his direct ownership stands at 12,416 shares of common stock, as reported in the Form 4 insider trading disclosure filed with regulators.

Was the SXI insider sale by Thomas E. Chorman part of a Rule 10b5-1 plan?

Yes. The sale was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025. Such pre-arranged trading plans schedule transactions in advance, which generally means the timing reflects the plan’s terms rather than a new discretionary decision.

Does the Standex International Form 4 show any option exercises or derivative transactions?

No. The Form 4 shows only a single non-derivative transaction: an open-market sale of 50 common shares. The derivativeSummary section is empty, indicating there were no reported option exercises, conversions, or other derivative-related activities in this particular filing.

How significant is the 50-share sale reported by the SXI director?

The filing reports a sale of 50 shares, after which the director still holds 12,416 shares. This indicates the transaction is small relative to his reported direct holdings and, combined with the pre-planned 10b5-1 status, appears consistent with routine portfolio management.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/02/2026 - 10:17 AM Accepted by SEC EDGAR 07/02/2026 - 10:16 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHORMAN THOMAS E

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM NEW HAMPSHIRE 03079

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S(1)		50	D	$355.51	12,416	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

	/s/ Alan J. Glass	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)